We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
6 July 2014
VISCHER advises AC Immune SA in Lausanne in its financing of CHF 20 million ($22.5 million) with existing private investors. The new funds will mainly support the newly initiated groundbreaking clinical trial of the anti-pTau vaccine ACI-35 with patients with mild or moderate Alzheimer’s disease. The VISCHER team is lead by Dr. Matthias Staehelin (Partner) with Christian Wyss (Managing Associate) and Marius Meier (Senior Associate), all Corporate/M&A.
Categories: Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Startup Desk, Deals & Cases
Attorney at Law and Civil Law Notary (BS/BL)
Attorney at Law
Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch...
Artiria Medical SA, a Swiss neurovascular MedTech company developing next-generation...
GlycoEra AG in Wädenswil, has increased its Series A Financing Round with a substantial additional...